FR94123E - Procédés pour fabriquer de nouvelles 4,5,6,7-tétrahydro-thiazolo[5,4-c]pyridines. - Google Patents

Procédés pour fabriquer de nouvelles 4,5,6,7-tétrahydro-thiazolo[5,4-c]pyridines.

Info

Publication number
FR94123E
FR94123E FR136259A FR136259A FR94123E FR 94123 E FR94123 E FR 94123E FR 136259 A FR136259 A FR 136259A FR 136259 A FR136259 A FR 136259A FR 94123 E FR94123 E FR 94123E
Authority
FR
France
Prior art keywords
thiazolo
pyridines
tetrahydro
processes
making new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR136259A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Application granted granted Critical
Publication of FR94123E publication Critical patent/FR94123E/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/02—Preparation by ring-closure or hydrogenation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • E—FIXED CONSTRUCTIONS
    • E02—HYDRAULIC ENGINEERING; FOUNDATIONS; SOIL SHIFTING
    • E02F—DREDGING; SOIL-SHIFTING
    • E02F9/00—Component parts of dredgers or soil-shifting machines, not restricted to one of the kinds covered by groups E02F3/00 - E02F7/00
    • E02F9/20—Drives; Control devices

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Mining & Mineral Resources (AREA)
  • Civil Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Structural Engineering (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FR136259A 1965-07-23 1968-01-16 Procédés pour fabriquer de nouvelles 4,5,6,7-tétrahydro-thiazolo[5,4-c]pyridines. Expired FR94123E (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DET0029055 1965-07-23
DET0032991 1967-01-16
DET0032992 1967-01-16
DET0032994 1967-01-16
DET0032990 1967-01-16
DET0032993 1967-01-16

Publications (1)

Publication Number Publication Date
FR94123E true FR94123E (fr) 1969-07-04

Family

ID=27512321

Family Applications (3)

Application Number Title Priority Date Filing Date
FR70538A Expired FR6013M (fr) 1965-07-23 1966-07-22
FR70539A Expired FR1498465A (fr) 1965-07-23 1966-07-22 Procédé pour fabriquer des nouvelles 4, 5, 6, 7-tétrahydro-thiazolo [5, 4-c] pyridines
FR136259A Expired FR94123E (fr) 1965-07-23 1968-01-16 Procédés pour fabriquer de nouvelles 4,5,6,7-tétrahydro-thiazolo[5,4-c]pyridines.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
FR70538A Expired FR6013M (fr) 1965-07-23 1966-07-22
FR70539A Expired FR1498465A (fr) 1965-07-23 1966-07-22 Procédé pour fabriquer des nouvelles 4, 5, 6, 7-tétrahydro-thiazolo [5, 4-c] pyridines

Country Status (7)

Country Link
BE (1) BE684415A (fr)
BR (1) BR6681517D0 (fr)
DE (1) DE1620508A1 (fr)
ES (9) ES329299A1 (fr)
FR (3) FR6013M (fr)
GB (1) GB1140387A (fr)
NL (2) NL6610324A (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5060904A (en) * 1987-05-01 1991-10-29 David Hegarty Multi-positionable support stand with movable center of gravity and article holding means
WO2001090094A1 (fr) * 2000-05-22 2001-11-29 Biovitrum Ab Inhibiteurs de 11-beta-hydroxy-steroide-deshydrogenase de type 1
US7094792B2 (en) 2001-11-22 2006-08-22 Biovitrum Ab Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
WO2019086494A1 (fr) * 2017-10-31 2019-05-09 F. Hoffmann-La Roche Ag Sulfones et sulfoxydes bicycliques et procédés d'utilisation associés
US11071721B2 (en) 2016-12-02 2021-07-27 Genentech, Inc. Bicyclic amide compounds and methods of use thereof
US11098058B2 (en) 2017-07-14 2021-08-24 Genentech, Inc. Bicyclic ketone compounds and methods of use thereof

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4847264A (en) * 1982-07-21 1989-07-11 Rorer Pharmaceutical Corporation Bicyclic nitrogen heterocyclic ethers and thioethers, and their pharmaceutical uses
GB8333514D0 (en) * 1983-12-16 1984-01-25 Erba Farmitalia Tetrahydrothiazolo(5 4-c)pyridine derivatives
EP0192098B1 (fr) 1985-02-06 1991-08-21 Boehringer Ingelheim Kg Utilisation de 2-amino-6-allyl-5,6,7,8-tétrahydro-4H-thiazolo[4,5-d]azépine pour la production d'un médicament pour le traitement de la maladie de Parkinson, respectivement du parkinsonisme
GB2173187B (en) * 1985-03-23 1988-05-18 Erba Farmitalia Condensed 2-substituted thiazole derivatives
DE69818094T2 (de) * 1997-12-11 2004-07-08 Biochem Pharma Inc., Laval Antivirale verbindungen
AR041952A1 (es) 2002-11-14 2005-06-01 Novartis Ag N-sulfonilaminotiazol
CL2004000553A1 (es) 2003-03-20 2005-02-04 Actelion Pharmaceuticals Ltd Uso de compuestos derivados de guanidina como antagonistas del receptor de neuropeptido ff; compuestos derivados de guanidina; procedimientos de preparacion; y composicion farmaceutica que los comprende.
CN101914107B (zh) 2003-11-12 2012-03-07 第一三共株式会社 噻唑衍生物的制备方法
US8541592B2 (en) 2005-11-22 2013-09-24 Amgen Inc. Inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1
WO2010071822A1 (fr) * 2008-12-19 2010-06-24 Schering Corporation Dérivés de pipéridine et de pipérazine et leurs méthodes d'utilisation
EP2414340A1 (fr) * 2009-04-03 2012-02-08 Dainippon Sumitomo Pharma Co., Ltd. Composés utilisables pour le traitement de troubles à médiation par le récepteur métabotropique 5 au glutamate et leurs procédés d'utilisation
CN109134510A (zh) * 2018-11-13 2019-01-04 井冈山大学 制备2-氨基-5-cbz-4,5,6,7-四氢噻唑并[5，4-c]吡啶的新方法

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5060904A (en) * 1987-05-01 1991-10-29 David Hegarty Multi-positionable support stand with movable center of gravity and article holding means
US7618961B2 (en) 2000-05-22 2009-11-17 Biovitrum Ab Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
WO2001090092A1 (fr) * 2000-05-22 2001-11-29 Biovitrum Ab Inhibiteurs de 11-beta-hydroxy-steroide-deshydrogenase de type 1
US7030135B2 (en) 2000-05-22 2006-04-18 Biovitrum Ab Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
US7132436B2 (en) 2000-05-22 2006-11-07 Biovitrum Ab Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
WO2001090094A1 (fr) * 2000-05-22 2001-11-29 Biovitrum Ab Inhibiteurs de 11-beta-hydroxy-steroide-deshydrogenase de type 1
US7094792B2 (en) 2001-11-22 2006-08-22 Biovitrum Ab Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
US7671051B2 (en) 2001-11-22 2010-03-02 Biovitrum Ab Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
US11071721B2 (en) 2016-12-02 2021-07-27 Genentech, Inc. Bicyclic amide compounds and methods of use thereof
US11607396B2 (en) 2016-12-02 2023-03-21 Genentech, Inc. Bicyclic amide compounds and methods of use thereof
US11098058B2 (en) 2017-07-14 2021-08-24 Genentech, Inc. Bicyclic ketone compounds and methods of use thereof
US11834461B2 (en) 2017-07-14 2023-12-05 Genentech, Inc. Bicyclic ketone compounds and methods of use thereof
JP2021501183A (ja) * 2017-10-31 2021-01-14 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 二環式のスルホン及びスルホキシド、並びにその使用方法
US11072617B2 (en) 2017-10-31 2021-07-27 Genentech, Inc. Bicyclic sulfones and sulfoxides and methods of use thereof
WO2019086494A1 (fr) * 2017-10-31 2019-05-09 F. Hoffmann-La Roche Ag Sulfones et sulfoxydes bicycliques et procédés d'utilisation associés

Also Published As

Publication number Publication date
FR6013M (fr) 1968-05-06
ES349322A1 (es) 1969-04-01
BR6681517D0 (pt) 1973-12-27
ES349319A1 (es) 1969-04-01
BE684415A (fr) 1967-01-20
NL6800589A (fr) 1968-07-17
GB1140387A (en) 1969-01-15
ES349320A1 (es) 1969-04-01
DE1620508A1 (de) 1969-09-18
FR1498465A (fr) 1967-10-20
ES349314A1 (es) 1969-04-01
ES349318A1 (es) 1969-04-01
ES349316A1 (es) 1969-04-01
ES349321A1 (es) 1969-04-01
NL6610324A (fr) 1967-01-24
ES329299A1 (es) 1968-02-16
ES349317A1 (es) 1969-04-01

Similar Documents

Publication Publication Date Title
FR94230E (fr) Procédés de soudage.
FR94123E (fr) Procédés pour fabriquer de nouvelles 4,5,6,7-tétrahydro-thiazolo[5,4-c]pyridines.
ES184330Y (es) Herramienta de torno.
FR1516781A (fr) Procédé pour fabriquer des nouvelles 1, 2, 3, 4-tétrahydro-9-aminoacridines
FI49716C (fi) Menetelmä 2,4-diamino-5-bentsyyli-pyrimidiinien valmistamiseksi.
DK112523B (da) Fremgangsmåde til fremstilling af 2,3-pyridindiol.
NL7403511A (nl) Smeltveiligheid.
FR1505795A (fr) Procédé pour fabriquer de nouvelles 11h-pyrido[2, 3-b][1, 5]benzodiazépine-5(6h)-ones substituées en position 11
DK112726B (da) Fremgangsmåde til fremstilling af 1,6-dibrom-1,6-didesoxydulcitol.
FR1434202A (fr) Procédé pour obtenir des nouvelles 5, 6-dihydro-5-oxo-11eta-pyrido [2, 3-b] [1, 5] benzodiazépines
NL7312521A (nl) Gereedschapsmachine.
FR1495865A (fr) Procédé pour fabriquer de nouveaux 1, 2, 5-thiadiazoles
DK115106B (da) Fremgangsmåde til rensning af 2,2,2-trifluor-1-klor-1-bromætan.
DK115184B (da) Fremgangsmåde til fremstilling af 6,7-benzomorphaner.
BE839062A (nl) Fermeture agrippante pour sangles ou bretelles reglables longitudinalement, particulierement pour soutien-gorge
FR95140E (fr) Procédé pour fabriquer de nouvelles pyridyl-tétrahydro-isoquinoléines.
FR1495709A (fr) Procédé de production de 5-alkylidènebicyclo[2. 2. 1]hept-2-ènes
DK120053B (da) Maskine til kontinuerlig smørfremstilling.
NL7412085A (nl) Gereedschapmachine.
CH550951A (fr) Materiau de calage pour machines-outils.
FI45755C (fi) Menetelmä 1,2-epoksi-9beta,10alfa-steroidien valmistamiseksi.
BE759628A (fr) Procede de preparation de nouveaux 3-carbamoyl-1-thia- isochromane-1,1-dioxydes n-substitues.
FR95699E (fr) Procédé pour fabriquer de nouvelles pyridyl-dihydroisoquinoléines.
DK118947B (da) Fremgangsmåde til fremstilling af 1,2-dihydro-4-hydroxyquinazolin-3-oxider.
FR94802E (fr) Procédé pour fabriquer des nouvelles 5,6-dihydro-11h-pyrido-[2,3-b] [1,4] benzodiazépines.